Filed before 2025Filed 13 July 2023
Venatorx Pharmaceuticals, Inc. has sold $35M so far
Venatorx Pharmaceuticals, Inc., a pharmaceuticals company based in Malvern, PA, has sold $35M so far in its debt round, according to a filing dated 13 July 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 13 July 2023
- First filed
- 27 February 2023
- Round
- Debt round (amended filing)
- Amount sold
- $35M
- Offering size
- $48.2M
- Investors so far
- 3
- Based in
- Malvern, PA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 89% of the 1,396 tracked raises with an amount filed in 2023.
Venatorx Pharmaceuticals, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 13 Jul 2023 | Amended filing | $35M | This raise |
| 27 Feb 2023 | New filing | $15M | This raise |
| 22 Dec 2022 | Amended filing | $24.7M | Another raise |
| 2 Sep 2022 | New filing | $12.7M | Another raise |
| 4 Apr 2022 | New filing | $34M | Another raise |
| 5 Nov 2018 | Amended filing | $27.1M | Another raise |
| 25 Jul 2017 | New filing | $21.9M | Another raise |
More with Abingworth Bioventures on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.